Pharmacy students in the U.S. show limited knowledge of HIV prophylaxis, especially PEP, due to inadequate assessment tools. Pharmacists are pivotal in HIV prevention, but their knowledge of PrEP ...

CDC: New HIV Pre-Exposure Prophylaxis Guidelines New clinical guidelines on HIV pre-exposure prophylaxis (PrEP) recommend the use of anti-HIV drugs by uninfected patients who are at substantial ...

Interview with Dr. Robert Goldstein on disparities in access to preexposure prophylaxis among populations at high risk for HIV infection. 8m 56s Download If current trends persist, one in six U.S ...

Preexposure prophylaxis with antiretroviral drugs has been effective in the prevention of human immunodeficiency virus (HIV) infection in some trials but not in others. In this randomized ...

Pre-exposure prophylaxis (PrEP) involving daily tenofovir disoproxil fumarate/emtricitabine 300/200 mg, taken orally, is a highly effective strategy for reducing the risk of HIV acquisition in adults ...

Pre-exposure prophylaxis (PrEP) is a highly effective modality for HIV prevention that can be prescribed by generalists. Pre-exposure prophylaxis should be offered to patients who are at high risk of ...

High adherence to antiretroviral pre-exposure prophylaxis (PrEP) is associated with a high level of protection from HIV acquisition by HIV-uninfected partners in heterosexual couples where only ...

Researchers demonstrate new modeling framework and use it to predict efficacy of different prophylaxis strategies ... which help prevent HIV infection. The framework, presented in PLOS ...

The FDA has approved Gilead’s combination drug Descovy for HIV prophylaxis in the US, offering a way of cutting the risk of sexually acquired infection with an improved safety profile compared ...

Michael W. Traeger, from the Burnet Institute in Melbourne, Australia, and colleagues describe STI incidence and behavioral risk factors among a cohort of 2,981 predominantly gay and bisexual men ...